Received May 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 3 | 945659 | IM / LA |
The patient had a negative titer drawn on 02/11/22. She was then given the Heplisav- 2 shot series which was completed 05/09/22. She should have had another titer drawn a month after her last dose, however, she did not. Today the nurse interpreted the information that the patient had her series completed and the titer came back as negative. The nurse was going to repeat the Hep B (Heplisav) series and have a titer redrawn. After administering the first dose of the second inoculation series the nurse noticed that the first series was given after the negative titer. Therefore, the patient received a booster when all she needed was another titer drawn to determine immunity.
NONE
NONE
UNKNOWN
NKA
HBsAB drawn on 05/01/2025